HYL · Hyloris Pharmaceuticals · Documents
Market Cap
124.60M EUR
Shares
28.00M
Hyloris Pharmaceuticals's financial reports and regulated publications, as filed with the market regulator, most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| ESEF Annual Report | 2026-05-12 | 2025-12-31 | |
| ESEF Annual Report | 2026-04-30 | 2025-12-31 | |
| ESEF Annual Report | 2026-04-30 | 2025-12-31 | |
| ESEF Annual Report | 2025-05-07 | 2024-12-31 | |
| ESEF Annual Report | 2025-04-30 | 2024-12-31 | |
| ESEF Annual Report | 2025-04-30 | 2024-12-31 | |
| ESEF Annual Report | 2025-04-30 | 2024-12-31 | |
| ESEF Annual Report | 2025-04-30 | 2024-12-31 | |
| ESEF Annual Report | 2024-12-18 | 2023-12-31 | |
| ESEF Annual Report | 2024-12-13 | 2023-12-31 | |
| ESEF Annual Report | 2024-12-13 | 2023-12-31 | |
| ESEF Annual Report | 2024-12-13 | 2023-12-31 | |
| ESEF Annual Report | 2024-12-13 | 2023-12-31 | |
| ESEF Annual Report | 2023-04-28 | 2022-12-31 | |
| ESEF Annual Report | 2023-04-28 | 2022-12-31 | |
| ESEF Annual Report | 2023-04-28 | 2022-12-31 | |
| ESEF Annual Report | 2023-04-28 | 2022-12-31 | |
| ESEF Annual Report | 2022-04-30 | 2021-12-31 | |
| ESEF Annual Report | 2022-04-30 | 2021-12-31 |
Showing 1–19 of 19 filings